Microfluidics Market to Witness Growth Acceleration by Top Key Players 2021 – Fluidigm Corporation, Agilent Technologies

The Global Microfluidics Market size is estimated to be USD 4.25 billion in 2019 and is predicted to reach USD 24.13 billion by 2030 with a CAGR of 17.1% from 2020-2030.

Microfluidics is a science studying the behavior of fluids through micro-channels It the technology use for developing microminiaturized devices. These miniature devices contain tunnels and chambers through which fluids flows. The microfluidics systems are process small amount of fluids by using tiny channels. These channels have dimensions ranging from tens to hundreds of micrometers. The systems are designed systems on the basis of technology technique known as photolithography. The technologies are in nascent stage but are rapidly emerging with wide range of applications in chemistry and biology.

Access Full Description of this report at:-

https://www.nextmsc.com/report/microfluidics-market

Top Companies: Illumina, Inc., Fluidigm Corporation, Agilent Technologies; Bio-Rad Laboratories, Inc., Caliper Life Sciences (PerkinElmer, Inc.), F. Hoffmann-La Roche Ltd, Cepheid, Danaher Corporation, Abbott Laboratories, and Life Technologies Corporation (Thermo Fisher Scientific, Inc.) and others.

Market Dynamics and Trends:

Increasing adoption of the point-of-care (POC) testing, extensive use of microfluidic systems in laboratory procedure and increase in the demand for microfluidic component such as microfluidics chips, pumps, and needles are major factor which are anticipated to drive the growth of the microfluidics market. Moreover, huge demand for fast & accurate testing through microfluidic chip miniaturization and increasing number of firms investing in microfluidics technologies. Factors that are expected to restrain the growth of the market are complex regulatory approval process, long time required for approval of products and lack of awareness about microfluidics technologies in developing nations in emerging regions such as Asia Pacific.

Developing healthcare infrastructure in the U.S. and other countries, increasing awareness about advantages of using microfluidic systems such minimal wastage of reagents and lowered procedure expenses, cost reduction and proper management of costly reagents in laboratories are other key factors that are expected to have a positive impact on the growth of the microfluidics market.

Request sample copy of this report at:-

https://www.nextmsc.com/microfluidics-market/request-sample

Market Segmentations and Scope of the Study:

Global microfluidics market share is analyzed on the basis of product, technology, application, end user and geography. On the basis of application, the market is segmented into pharmaceutical, in vitro diagnostics, and medical devices. The pharmaceutical segment is further divided into proteomics, genomics, cell based assays and others. The in vitro diagnostics segment is further divided into point-of-care (POC), clinical, environmental and industrial applications. On the basis of material, the market is segmented into polymer, glass, silicon, metal, ceramics and others. On the basis of end user, the market is segmented into hospitals, ambulatory care centers, and home healthcare. The ambulatory care centers segments are expected to hold significant market share during the forecast period and is expected to be driven by increasing the application of microfluidics in ambulatory care centers, especially in the U.S. and European countries such as Germany, UK and France. The regional analysis of the market comprises of North America, Europe, Asia Pacific, and Rest of the World.

Geographical Analysis:

Globally, North America is expected to account for largest market share and is expected to continue its growth during the forecast period. In the U.S., increase in the use of microfluidic systems in laboratories and research centers as well as and growing application of microfluidics in pharmaceuticals and forensics.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.